SEARCH

SEARCH BY CITATION

References

  • 1
    DeMaeyer E & Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985; 38:30216.
  • 2
    Cook JD & Lunch SR. The liabilities of iron deficiency. Blood 1986; 68:8039.
  • 3
    Chandra RK. Trace element regulation of immunity and infection. J A Coll Nutr 1985; 4:516.
  • 4
    Van Heerden C, Oosthuizen R, Van Wyk H, Prinsloo P, Anderson R. Evaluation of neutrophil and lymphocyte function in subjects with iron deficiency. S African Med J 1981; 59:1113.
  • 5
    Dhur A, Galan P, Hercberg S. Iron status, immune capacity and resistance to infection. Comp Biochem Physiol A Mol Integr Physiol 1989; 94:119.
  • 6
    Strauss RG. Iron deficiency, infections, and immune function: a reassessment. Am J Clin Nutr 1978; 31:6606.
  • 7
    Farthing MJ. Iron and immunity. Acta Paediatr Scand 1989; 361(Suppl.):4452.
  • 8
    Dennison HA. Limitations of ferritin as a marker of anemia in end stage renal disease. Anna J 1999; 26:40914.
  • 9
    Feelders RA, Kuiper-Kramer EP, Van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 1999; 37:110.
  • 10
    Thibault H, Galan P, Selz F et al. The immune response in iron-deficient young children: effect of iron supplementation on cell-mediated immunity. Eur J Pediatr 1993; 152:1204.
  • 11
    Kling PJ, Roberts RA, Widness JA. Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants. J Pediatr Hematol/Oncol 1998; 20:30914.
  • 12
    Suominen P, Punnonen K, Rajamäki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998; 92:29349.
  • 13
    Ahluwalia N. Diagnostic utility of serum transferrin receptors measurement in assessingiron status. Nutr Rev 1998; 56:13341.
  • 14
    Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992; 19:38590.
  • 15
    Keevil B, Rowlands D, Burton I, Webb AK. Assessment of iron status in cystic fibrosis patients. Ann Clin Biochem 2000; 37:6625.
  • 16
    Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med 1993; 44:6274.
  • 17
    Virtanen MA, Viinikka LU, Virtanen MK et al. Higher concentrations of serum transferrin receptor in children than adults. Am J Clin Nutr 1999; 69:25660.
  • 18
    Jason J, Archibald L, McDonald C et al. Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infections. Clin Diagn Lab Immunol 1999; 6:738.
  • 19
    Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998; 44:4551.
  • 20
    Kuvibidila S, Mark JA, Warrier RP, Yu L, Ode D. Soluble transferrin receptor as an index of iron status in Zaïrian children with malaria. Am J Trop Med Hyg 1995; 98:3738.
  • 21
    Kuiper-Kramer EP, Huisman CMS, Van Raan J, Van Eijk HG. Analytical and clinical implications of soluble transferrin receptors in serum. Eur J Clin Chem Clin Biochem 1996; 34:6459.
  • 22
    Skikne BS. Circulating transferrin receptor assay – coming of age [editorial; comment]. Clin Chem 1998; 44:79.
  • 23
    Smith KR, Veranth JM, Hu AA, Lighty JS, Aust AE. Interleukin-8 levels in human lung epithelial cells are increased in response to coal fly ash and vary with the bioavailability of iron, as a function of particle size and source of coal. Chem Res Toxicol 2000; 13:11825.
  • 24
    Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 1994; 19:146875.
  • 25
    Hirayama M, Kohgo Y, Kondo H et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993; 18:87480.
  • 26
    Le J & Vilèek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61:588602.
  • 27
    Asano S, Okano A, Ozawa K et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990; 75:16025.
  • 28
    Fahmy M & Young SP. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 1993; 296:17581.
  • 29
    Gabriel A, Kozek S, Chiari A et al. High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998; 44:3617.
  • 30
    Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997; 158:4205.
  • 31
    Owen-Schaub LB, Gutterman JU, Grimm EA. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor-α and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res 1988; 48:78892.
  • 32
    Itoh K, Shiba K, Shimizu Y, Suzuki R, Kumagai K. Generation of activated killer (AK) cells by recombinant interleukin 2 in collaboration with interferon-γ. J Immunol 1985; 134:31249.